Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Novel TNF-α receptor 1 antagonist treatment attenuates arterial inflammation and intimal hyperplasia in mice.

Kitagaki M, Isoda K, Kamada H, Kobayashi T, Tsunoda S, Tsutsumi Y, Niida T, Kujiraoka T, Ishigami N, Ishihara M, Matsubara O, Ohsuzu F, Kikuchi M.

J Atheroscler Thromb. 2012;19(1):36-46. Epub 2011 Dec 7.

2.

Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury.

Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken AH.

Am J Physiol Regul Integr Comp Physiol. 2002 Aug;283(2):R505-12.

PMID:
12121864
3.
4.

PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.

Zhang LL, Gao CY, Fang CQ, Wang YJ, Gao D, Yao GE, Xiang J, Wang JZ, Li JC.

Cardiovasc Res. 2011 Dec 1;92(3):484-93. doi: 10.1093/cvr/cvr238. Epub 2011 Aug 31.

PMID:
21880694
5.

The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development.

de Jong RCM, Ewing MM, de Vries MR, Karper JC, Bastiaansen AJNM, Peters HAB, Baghana F, van den Elsen PJ, Gongora C, Jukema JW, Quax PHA.

PLoS One. 2017 Oct 10;12(10):e0185820. doi: 10.1371/journal.pone.0185820. eCollection 2017.

6.

Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.

Bäck M, Bu DX, Bränström R, Sheikine Y, Yan ZQ, Hansson GK.

Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17501-6. Epub 2005 Nov 17.

7.

Relative contribution of the TNF-alpha receptors to murine intimal hyperplasia.

Zimmerman MA, Reznikov LL, Sorensen AC, Selzman CH.

Am J Physiol Regul Integr Comp Physiol. 2003 May;284(5):R1213-8. Epub 2003 Jan 16.

PMID:
12531783
8.

Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice.

Nomura T, Abe Y, Kamada H, Shibata H, Kayamuro H, Inoue M, Kawara T, Arita S, Furuya T, Yamashita T, Nagano K, Yoshikawa T, Yoshioka Y, Mukai Y, Nakagawa S, Taniai M, Ohta T, Serada S, Naka T, Tsunoda S, Tsutsumi Y.

J Control Release. 2011 Jan 5;149(1):8-14. doi: 10.1016/j.jconrel.2009.12.015. Epub 2009 Dec 24.

PMID:
20036293
9.

Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.

Zuckerbraun BS, McCloskey CA, Mahidhara RS, Kim PK, Taylor BS, Tzeng E.

J Vasc Surg. 2003 Oct;38(4):812-9.

10.

The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF.

Shibata H, Yoshioka Y, Abe Y, Ohkawa A, Nomura T, Minowa K, Mukai Y, Nakagawa S, Taniai M, Ohta T, Kamada H, Tsunoda S, Tsutsumi Y.

Biomaterials. 2009 Dec;30(34):6638-47. doi: 10.1016/j.biomaterials.2009.08.041. Epub 2009 Sep 17.

PMID:
19765818
11.
12.

A new RXR agonist, HX630, suppresses intimal hyperplasia in a mouse blood flow cessation model.

Haraguchi G, Suzuki J, Kosuge H, Ogawa M, Koga N, Muto S, Itai A, Kagechika H, Shudo K, Isobe M.

J Mol Cell Cardiol. 2006 Nov;41(5):885-92. Epub 2006 Sep 11.

PMID:
16963076
13.

Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery.

Takaoka M, Uemura S, Kawata H, Imagawa K, Takeda Y, Nakatani K, Naya N, Horii M, Yamano S, Miyamoto Y, Yoshimasa Y, Saito Y.

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2083-9. Epub 2006 Jun 15.

14.

Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.

Takigawa T, Tsurushima H, Suzuki K, Tsuruta W, Nakamura K, Matsumura A.

J Vasc Surg. 2012 Feb;55(2):506-16. doi: 10.1016/j.jvs.2011.07.087.

15.

IκBNS regulates interleukin-6 production and inhibits neointimal formation after vascular injury in mice.

Niida T, Isoda K, Kitagaki M, Ishigami N, Adachi T, Matsubara O, Takeda K, Kishimoto T, Ohsuzu F.

Cardiovasc Res. 2012 Feb 1;93(2):371-9. doi: 10.1093/cvr/cvr323. Epub 2011 Dec 1.

PMID:
22135163
16.

Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist.

Shibata H, Yoshioka Y, Ohkawa A, Minowa K, Mukai Y, Abe Y, Taniai M, Nomura T, Kayamuro H, Nabeshi H, Sugita T, Imai S, Nagano K, Yoshikawa T, Fujita T, Nakagawa S, Yamamoto A, Ohta T, Hayakawa T, Mayumi T, Vandenabeele P, Aggarwal BB, Nakamura T, Yamagata Y, Tsunoda S, Kamada H, Tsutsumi Y.

J Biol Chem. 2008 Jan 11;283(2):998-1007. Epub 2007 Nov 14.

17.
18.

Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model.

Faries PL, Marin ML, Veith FJ, Ramirez JA, Suggs WD, Parsons RE, Sanchez LA, Lyon RT.

J Vasc Surg. 1996 Sep;24(3):463-71.

19.
20.

Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.

Guo G, Morrissey J, McCracken R, Tolley T, Klahr S.

Am J Physiol. 1999 Nov;277(5 Pt 2):F766-72.

PMID:
10564241

Supplemental Content

Support Center